Dar Bioscience CEO at BIO Convention
Analysis based on 6 articles · First reported Jun 18, 2026 · Last updated Jun 18, 2026
The participation of Dar Bioscience and its CEO, Sabrina Martucci Johnson, at the Cape Town International Convention Centre 2026 could positively impact the company's stock price due to increased visibility, potential partnerships, and investor interest in its women's health portfolio. This event highlights the growing importance of the women's health sector within the biotechnology industry.
Dar Bioscience, a health biotech company focused on women's health, announced that its President and CEO, Sabrina Martucci Johnson, will participate in multiple speaking engagements and deliver a corporate presentation at the Cape Town International Convention Centre 2026 in United States — San Diego, California. The convention, a premier global gathering for the biotechnology industry, will feature Ms. Johnson speaking on panels such as 'Invest in United States — San Diego Breakfast', 'WIB@BIO 2026 Executive Breakfast', and 'Are We There Yet: The Road to Clinical Development in Women's Health'. She will also present Dar Bioscience's corporate strategy and development portfolio, aiming to highlight the company's commitment to addressing critical gaps in women's healthcare and creating value for patients, partners, and shareholders.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard